290 related articles for article (PubMed ID: 29630020)
1. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
2. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
3. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
4. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment.
Uppal S; Chapman C; Spencer RJ; Jolly S; Maturen K; Rauh-Hain JA; delCarmen MG; Rice LW
Obstet Gynecol; 2017 Feb; 129(2):295-304. PubMed ID: 28079775
[TBL] [Abstract][Full Text] [Related]
5. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
Bristow RE; Chang J; Ziogas A; Anton-Culver H
Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
[TBL] [Abstract][Full Text] [Related]
6. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
7. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
8. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
Bristow RE; Chang J; Villanueva C; Ziogas A; Vieira VM
Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
[TBL] [Abstract][Full Text] [Related]
9. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
10. Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States.
Howard JM; Nandy K; Woldu SL; Margulis V
JAMA Netw Open; 2021 Jun; 4(6):e2112813. PubMed ID: 34106265
[TBL] [Abstract][Full Text] [Related]
11. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
12. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
[TBL] [Abstract][Full Text] [Related]
13. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.
Graboyes EM; Garrett-Mayer E; Sharma AK; Lentsch EJ; Day TA
Cancer; 2017 Jul; 123(14):2651-2660. PubMed ID: 28241092
[TBL] [Abstract][Full Text] [Related]
14. Trends in guideline-adherent fertility-sparing surgery for early-stage cervical cancer before and after the Affordable Care Act.
Sutaria T; Sparks AD; Rao YJ; Lopez-Acevedo M; Long B
Gynecol Oncol; 2020 Aug; 158(2):424-430. PubMed ID: 32534810
[TBL] [Abstract][Full Text] [Related]
15. Variation in care in concurrent chemotherapy administration during radiation for locally advanced cervical cancer.
Uppal S; Del Carmen MG; Rice LW; Reynolds RK; Jolly S; Bregar A; Abdelsattar ZM; Rauh-Hain JA
Gynecol Oncol; 2016 Aug; 142(2):286-92. PubMed ID: 27234144
[TBL] [Abstract][Full Text] [Related]
16. Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
Rodriguez VE; LeBrón AMW; Chang J; Bristow RE
Cancer; 2021 Jul; 127(14):2423-2431. PubMed ID: 33721357
[TBL] [Abstract][Full Text] [Related]
17. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
[TBL] [Abstract][Full Text] [Related]
18. Racial-Ethnic and Socioeconomic Disparities in Guideline-Adherent Treatment for Endometrial Cancer.
Rodriguez VE; LeBrón AMW; Chang J; Bristow RE
Obstet Gynecol; 2021 Jul; 138(1):21-31. PubMed ID: 34259460
[TBL] [Abstract][Full Text] [Related]
19. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
Wu J; Huang Y; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Hershman DL; Wright JD
Gynecol Oncol; 2020 Nov; 159(2):309-316. PubMed ID: 32800656
[TBL] [Abstract][Full Text] [Related]
20. Population-Based Analysis of National Comprehensive Cancer Network (NCCN) Guideline Adherence for Patients with Anal Squamous Cell Carcinoma in California.
Kumar P; Del Rosario M; Chang J; Ziogas A; Jafari MD; Bristow RE; Tanjasiri SP; Zell JA
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
